Sodium-Phosphate Cotransporter Proteins, Type IIb
"Sodium-Phosphate Cotransporter Proteins, Type IIb" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
A sodium-dependent phosphate transporter present primarily at apical sites of EPITHELIAL CELLS in the SMALL INTESTINE.
MeSH Number(s)
D12.776.157.530.450.074.750.750.750.249
D12.776.157.530.450.625.625.750.249
D12.776.157.648.500.750.750.249
D12.776.543.585.450.074.750.750.750.249
D12.776.543.585.450.625.625.750.249
Concept/Terms
Sodium-Phosphate Cotransporter Proteins, Type IIb- Sodium-Phosphate Cotransporter Proteins, Type IIb
- Sodium Phosphate Cotransporter Proteins, Type IIb
- Type IIb Sodium-Phosphate Cotransporter Proteins
- Type IIb Sodium Phosphate Cotransporter Proteins
- Type IIb Sodium-Phosphate Symporter Proteins
- Type IIb Sodium Phosphate Symporter Proteins
- NPTIIb Transporter Proteins
- Transporter Proteins, NPTIIb
Below are MeSH descriptors whose meaning is more general than "Sodium-Phosphate Cotransporter Proteins, Type IIb".
- Chemicals and Drugs [D]
- Amino Acids, Peptides, and Proteins [D12]
- Proteins [D12.776]
- Carrier Proteins [D12.776.157]
- Membrane Transport Proteins [D12.776.157.530]
- Ion Pumps [D12.776.157.530.450]
- Anion Transport Proteins [D12.776.157.530.450.074]
- Phosphate Transport Proteins [D12.776.157.530.450.074.750]
- Sodium-Phosphate Cotransporter Proteins [D12.776.157.530.450.074.750.750]
- Sodium-Phosphate Cotransporter Proteins, Type II [D12.776.157.530.450.074.750.750.750]
- Sodium-Phosphate Cotransporter Proteins, Type IIb [D12.776.157.530.450.074.750.750.750.249]
- Symporters [D12.776.157.530.450.625]
- Sodium-Phosphate Cotransporter Proteins [D12.776.157.530.450.625.625]
- Sodium-Phosphate Cotransporter Proteins, Type II [D12.776.157.530.450.625.625.750]
- Sodium-Phosphate Cotransporter Proteins, Type IIb [D12.776.157.530.450.625.625.750.249]
- Phosphate-Binding Proteins [D12.776.157.648]
- Phosphate Transport Proteins [D12.776.157.648.500]
- Sodium-Phosphate Cotransporter Proteins [D12.776.157.648.500.750]
- Sodium-Phosphate Cotransporter Proteins, Type II [D12.776.157.648.500.750.750]
- Sodium-Phosphate Cotransporter Proteins, Type IIb [D12.776.157.648.500.750.750.249]
- Membrane Proteins [D12.776.543]
- Membrane Transport Proteins [D12.776.543.585]
- Ion Pumps [D12.776.543.585.450]
- Anion Transport Proteins [D12.776.543.585.450.074]
- Phosphate Transport Proteins [D12.776.543.585.450.074.750]
- Sodium-Phosphate Cotransporter Proteins [D12.776.543.585.450.074.750.750]
- Sodium-Phosphate Cotransporter Proteins, Type II [D12.776.543.585.450.074.750.750.750]
- Sodium-Phosphate Cotransporter Proteins, Type IIb [D12.776.543.585.450.074.750.750.750.249]
- Symporters [D12.776.543.585.450.625]
- Sodium-Phosphate Cotransporter Proteins [D12.776.543.585.450.625.625]
- Sodium-Phosphate Cotransporter Proteins, Type II [D12.776.543.585.450.625.625.750]
- Sodium-Phosphate Cotransporter Proteins, Type IIb [D12.776.543.585.450.625.625.750.249]
Below are MeSH descriptors whose meaning is more specific than "Sodium-Phosphate Cotransporter Proteins, Type IIb".
This graph shows the total number of publications written about "Sodium-Phosphate Cotransporter Proteins, Type IIb" by people in Harvard Catalyst Profiles by year, and whether "Sodium-Phosphate Cotransporter Proteins, Type IIb" was a major or minor topic of these publication.
To see the data from this visualization as text,
click here.
Year | Major Topic | Minor Topic | Total |
---|
2014 | 0 | 1 | 1 |
2016 | 0 | 1 | 1 |
2018 | 0 | 1 | 1 |
2019 | 1 | 2 | 3 |
2020 | 1 | 0 | 1 |
Below are the most recent publications written about "Sodium-Phosphate Cotransporter Proteins, Type IIb" by people in Profiles.
-
Expression of NaPi-IIb in rodent and human kidney and upregulation in a model of chronic kidney disease. Pflugers Arch. 2020 04; 472(4):449-460.
-
Functional significance of U2AF1 S34F mutations in lung adenocarcinomas. Nat Commun. 2019 12 13; 10(1):5712.
-
Phase Ia Study of Anti-NaPi2b Antibody-Drug Conjugate Lifastuzumab Vedotin DNIB0600A in Patients with Non-Small Cell Lung Cancer and Platinum-Resistant Ovarian Cancer. Clin Cancer Res. 2020 01 15; 26(2):364-372.
-
Antibody-drug conjugates in gynecologic malignancies. Gynecol Oncol. 2019 06; 153(3):694-702.
-
Differential Subcellular Localization Regulates Oncogenic Signaling by ROS1 Kinase Fusion Proteins. Cancer Res. 2019 02 01; 79(3):546-556.
-
ADAM17 substrate release in proximal tubule drives kidney fibrosis. JCI Insight. 2016 Aug 18; 1(13).
-
Clinical and the prognostic characteristics of lung adenocarcinoma patients with ROS1 fusion in comparison with other driver mutations in East Asian populations. J Thorac Oncol. 2014 Aug; 9(8):1171-9.
-
TGF-beta promotes cell death and suppresses lactation during the second stage of mammary involution. J Cell Physiol. 2009 Apr; 219(1):57-68.